1. Home
  2. ERIE vs MEDP Comparison

ERIE vs MEDP Comparison

Compare ERIE & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erie Indemnity Company

ERIE

Erie Indemnity Company

HOLD

Current Price

$232.39

Market Cap

13.3B

Sector

Finance

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$409.86

Market Cap

14.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERIE
MEDP
Founded
1925
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
14.9B
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
ERIE
MEDP
Price
$232.39
$409.86
Analyst Decision
Hold
Analyst Count
0
12
Target Price
N/A
$497.17
AVG Volume (30 Days)
169.4K
366.2K
Earning Date
04-23-2026
04-22-2026
Dividend Yield
2.35%
N/A
EPS Growth
N/A
20.98
EPS
491.00
4.28
Revenue
$1,691,774,000.00
N/A
Revenue This Year
$6.83
$13.19
Revenue Next Year
N/A
$7.75
P/E Ratio
$0.51
$25.57
Revenue Growth
5.96
N/A
52 Week Low
$233.82
$284.10
52 Week High
$380.67
$628.92

Technical Indicators

Market Signals
Indicator
ERIE
MEDP
Relative Strength Index (RSI) 37.84 32.12
Support Level N/A $306.70
Resistance Level $257.79 $485.13
Average True Range (ATR) 9.14 18.97
MACD -0.48 -10.95
Stochastic Oscillator 9.60 22.67

Price Performance

Historical Comparison
ERIE
MEDP

About ERIE Erie Indemnity Company

Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: